CWM
SZYM

Cabot Wealth Management’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Cabot Wealth Management’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-98,936
Closed -$1.07M – 165
2013
Q3 		$1.07M Buy
98,936
+252
+0.3% +$2.87K 0.32% 103
2013
Q2 		$1.16M Buy
+98,684
New +$986K 0.4% 92

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cabot Wealth Management's SZYM Position: Q4 2013 in Review

Cabot Wealth Management sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q4 2013, closing a stake of 98,936 shares — an estimated $1.07M sold.

Cabot Wealth Management first reported a position in SZYM in Q2 2013 and held it in 2 quarters. The position peaked at $1.16M in Q2 2013. 105 funds tracked by Wall St. Rank hold SZYM as of Q4 2013.

  • Cabot Wealth Management reported no remaining SOLAZYME INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • Cabot Wealth Management sold 98,936 SOLAZYME INC COM STK (DE) shares in Q4 2013, an estimated $1.07M.
  • Cabot Wealth Management first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 2 quarters.
  • Cabot Wealth Management's SOLAZYME INC COM STK (DE) position peaked at $1.16M in Q2 2013.
  • 105 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q4 2013.

Based on Cabot Wealth Management's 13F filing for Q4 2013, filed 11 Feb 2014.